Wells Fargo Maintains Equal-Weight on Teva Pharmaceutical Indus, Raises Price Target to $10
Wells Fargo maintains Teva Pharmaceutical Indus (NYSE:TEVA) with a Equal-Weight and raises the price target from $8 to…
Amarin Shares Rebound From Session Low, Now Up 1% For Session; Traders Circulate Link From Cigna Website Showing Changes To Prescription Drug List, Co. Added Amarin’s Vascepa To National Coverage List
https://www.cigna.com/static/www-cigna-com/docs/individuals-families/2019/2020-prescription-drug-list-changes.pdf
Wells Fargo Maintains Overweight on Karuna Therapeutics, Raises Price Target to $137
Wells Fargo maintains Karuna Therapeutics (NASDAQ:KRTX) with a Overweight and raises the price target from $106 to $137.
Benzinga’s Top Upgrades, Downgrades For January 22, 2020
Upgrades Citigroup changed the rating for Comerica Inc (NYSE:CMA) from Sell to Neutral. Comerica earned $1.85 in the fourth quarter, compared…
Morgan Stanley Maintains Equal-Weight on Wynn Resorts, Raises Price Target to $152
Morgan Stanley maintains Wynn Resorts (NASDAQ:WYNN) with a Equal-Weight and raises the price target from $120 to $152.
Morgan Stanley Maintains Underweight on Williams-Sonoma, Raises Price Target to $68
Morgan Stanley maintains Williams-Sonoma (NYSE:WSM) with a Underweight and raises the price target from $60 to $68.
Analyst: Casino Sell-Offs ‘Could Be An Overreaction’ To Wuhan Coronavirus
Macau casino stocks were hammered on Tuesday as investors worried fears over the deadly coronavirus in China would…
Morgan Stanley Maintains Underweight on Spire, Raises Price Target to $83
Morgan Stanley maintains Spire (NYSE:SR) with a Underweight and raises the price target from $80 to $83.